Progressive external ophthalmoplegia, autosomal dominant, type 2 (Q97271): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 13:22, 16 August 2026
Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions-2 (PEOA2) is caused by heterozygous mutation in the nuclear-encoded ANT1 gene (SLC25A4; 103220) on chromosome 4q35. The most common clinical features include adult onset of weakness of the external eye muscles and exercise intolerance. Progressive external ophthalmoplegia caused by mutations in the POLG gene are associated with more complicated phenotypes than those forms caused by mutations in the ANT1 or C10ORF2 genes.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_446775180 |
||
| English | Progressive external ophthalmoplegia, autosomal dominant, type 2 |
Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions-2 (PEOA2) is caused by heterozygous mutation in the nuclear-encoded ANT1 gene (SLC25A4; 103220) on chromosome 4q35. The most common clinical features include adult onset of weakness of the external eye muscles and exercise intolerance. Progressive external ophthalmoplegia caused by mutations in the POLG gene are associated with more complicated phenotypes than those forms caused by mutations in the ANT1 or C10ORF2 genes. |
Statements
CID11:ID_446775180
0 references
dki-india-ID_446775180
0 references
Concluído
0 references
15 August 2026
0 references
